ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Pallab12
|
1.5K |
560K |
5 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
1.5K
|
560K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Pallab12
|
1.5K |
560K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1.5K
|
560K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Pallab12
|
689 |
319K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
689
|
319K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Pallab12
|
689 |
319K |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
689
|
319K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Pallab12
|
689 |
319K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
689
|
319K
|
1
|
|
ASX - By Stock
|
KMD |
Re:
Ann: Half Yearly Report and Accounts
|
|
Pallab12
|
16 |
4.7K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
16
|
4.7K
|
1
|
|
ASX - By Stock
|
KMD |
Re:
Ann: Half Yearly Report and Accounts
|
|
Pallab12
|
16 |
4.7K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
16
|
4.7K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Pallab12
|
1.5K |
560K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.5K
|
560K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Pallab12
|
422 |
189K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
422
|
189K
|
0
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK agrees to scheme agreement with PAR Technology
|
|
Pallab12
|
62 |
22K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
62
|
22K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: India update
|
|
Pallab12
|
113 |
40K |
29 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
113
|
40K
|
29
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix to Acquire ARTMS (Isotope Production Platform)
|
|
Pallab12
|
43 |
17K |
8 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
43
|
17K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix to Acquire ARTMS (Isotope Production Platform)
|
|
Pallab12
|
43 |
17K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
43
|
17K
|
10
|
|
ASX - By Stock
|
BTH |
Re:
Ann: Half Year Financial Report and Appendix 4D
|
|
Pallab12
|
43 |
16K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
43
|
16K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Bets on price action tomorrow! go
|
|
Pallab12
|
1 |
740 |
12 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1
|
740
|
12
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Pallab12
|
130 |
42K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
130
|
42K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Pallab12
|
130 |
42K |
5 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
130
|
42K
|
5
|
|
ASX - By Stock
|
PLS |
Re:
Ann: FY24 Interim Financial Results
|
|
Pallab12
|
110 |
66K |
15 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
110
|
66K
|
15
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CEO Letter to Shareholders
|
|
Pallab12
|
12 |
5.5K |
1 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
12
|
5.5K
|
1
|
|
ASX - By Stock
|
SLR |
Re:
Ann: Presentation - Red 5 and Silver Lake Resources to Merge
|
|
Pallab12
|
206 |
104K |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
206
|
104K
|
2
|
|
ASX - By Stock
|
LTR |
Re:
ASX Today
|
|
Pallab12
|
40K |
17M |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
40K
|
17M
|
4
|
|
ASX - By Stock
|
ART |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pallab12
|
18 |
4.5K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
18
|
4.5K
|
0
|
|
ASX - By Stock
|
BIO |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
Pallab12
|
13 |
3.9K |
1 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
13
|
3.9K
|
1
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Ceasing to be a substantial holder from WAM, WMI & WAA
|
|
Pallab12
|
1 |
935 |
1 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
1
|
935
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
Pallab12
|
6 |
3.9K |
4 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
6
|
3.9K
|
4
|
|
ASX - By Stock
|
BIO |
Re:
Ann: FY24 Revenue Guidance Upgrade to $12.5M
|
|
Pallab12
|
60 |
16K |
2 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference Presentation
|
|
Pallab12
|
62 |
24K |
3 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
62
|
24K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Pallab12
|
315 |
155K |
3 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
315
|
155K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Pallab12
|
315 |
155K |
13 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Pallab12
|
315 |
155K |
18 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
18
|
|
ASX - By Stock
|
DLI |
Re:
Ann: Change in substantial holding Idemitsu
|
|
Pallab12
|
45 |
9.6K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
45
|
9.6K
|
0
|
|
ASX - By Stock
|
DLI |
Re:
Ann: Change in substantial holding Idemitsu
|
|
Pallab12
|
45 |
9.6K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
45
|
9.6K
|
1
|
|
Charts
|
LRS |
Re:
LRS chart
|
|
Pallab12
|
7.2K |
2.8M |
2 |
11/12/23 |
11/12/23 |
Charts
|
7.2K
|
2.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Pallab12
|
9.9K |
4.4M |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Pallab12
|
9.9K |
4.4M |
6 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Pallab12
|
9.9K |
4.4M |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
1
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Change of Director's Interest Notice
|
|
Pallab12
|
20 |
7.4K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
20
|
7.4K
|
1
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Change of Director's Interest Notice
|
|
Pallab12
|
20 |
7.4K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
20
|
7.4K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
|
|
Pallab12
|
51 |
27K |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
51
|
27K
|
4
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Change of Director's Interest Notice
|
|
Pallab12
|
20 |
7.4K |
0 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
20
|
7.4K
|
0
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Change of Director's Interest Notice
|
|
Pallab12
|
20 |
7.4K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
20
|
7.4K
|
1
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Sale of Shares
|
|
Pallab12
|
8 |
3.6K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
8
|
3.6K
|
0
|
|
ASX - By Stock
|
DUG |
Re:
Ann: Sale of Shares
|
|
Pallab12
|
8 |
3.6K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
8
|
3.6K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Pallab12
|
9.9K |
4.4M |
4 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
4
|
|
ASX - By Stock
|
DUG |
Re:
Ann: FY2023 Results Release
|
|
Pallab12
|
19 |
10K |
0 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
19
|
10K
|
0
|
|
ASX - By Stock
|
LTR |
Re:
Ann: Revised Proposal from Albemarle
|
|
Pallab12
|
1.0K |
417K |
5 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
417K
|
5
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Pallab12
|
1.1K |
519K |
4 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.1K
|
519K
|
4
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Pallab12
|
1.1K |
519K |
45 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
1.1K
|
519K
|
45
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 1H 2023 Results Presentation
|
|
Pallab12
|
102 |
29K |
5 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
102
|
29K
|
5
|
|
ASX - By Stock
|
ART |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pallab12
|
15 |
7.9K |
5 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
15
|
7.9K
|
5
|
|